Jun 11 2024;doi:10.1101/2023.01.31.23285059 Sorensen M, Pershagen G, Thacher JD, et al
This characteristic renders PPAR agonists potentially applicable to patients with GA and hyperuricemia associated with cyclic FA disorders (127, 128), which reduce FA levels by suppressing lipolysis and do not selectively regulate specific types of FAs, and may, therefore, be applicable for the prevention and treatment of patients at risk of elevated circulating FA levels
Few generics are in development
Complexe de vitamine C microencapsule (acide ascorbique, ascorbate de sodium, anti-agglomrant : carbonate acide de magnsium, mulsifiant : lcithines, stabilisant : glycrol, dulcorant : glycosides de stviol issus de Stevia)